ARF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.71510036675693E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.23097145996599E-12 |
Normal-vs-Stage2 |
6.43210000039751E-07 |
Normal-vs-Stage3 |
3.2318000053877E-08 |
Normal-vs-Stage4 |
1.478350E-02 |
Stage1-vs-Stage2 |
5.413800E-01 |
Stage1-vs-Stage3 |
8.564200E-01 |
Stage1-vs-Stage4 |
3.894000E-02 |
Stage2-vs-Stage3 |
7.321600E-01 |
Stage2-vs-Stage4 |
1.561610E-01 |
Stage3-vs-Stage4 |
8.733800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.57590002053598E-09 |
Normal-vs-AfricanAmerican |
2.46239695300687E-11 |
Normal-vs-Asian |
2.624600E-03 |
Caucasian-vs-AfricanAmerican |
4.652200E-02 |
Caucasian-vs-Asian |
5.483600E-01 |
AfricanAmerican-vs-Asian |
9.179400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.53559950813553E-10 |
Normal-vs-Female |
5.46779954646581E-10 |
Male-vs-Female |
6.196200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.223300E-04 |
Normal-vs-Age(41-60Yrs) |
6.50130005386274E-09 |
Normal-vs-Age(61-80Yrs) |
9.06829999980374E-09 |
Normal-vs-Age(81-100Yrs) |
7.05299999959053E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.401800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.494200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.678150E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.389400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.463760E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.467600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.979370E-04 |
Normal-vs-Grade 2 |
3.40527606113028E-12 |
Normal-vs-Grade 3 |
2.1371016067917E-11 |
Normal-vs-Grade 4 |
2.464100E-02 |
Grade 1-vs-Grade 2 |
5.400800E-01 |
Grade 1-vs-Grade 3 |
6.339600E-01 |
Grade 1-vs-Grade 4 |
4.944400E-02 |
Grade 2-vs-Grade 3 |
4.788400E-01 |
Grade 2-vs-Grade 4 |
8.565900E-02 |
Grade 3-vs-Grade 4 |
4.666200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.46864767411626E-13 |
Normal-vs-ccB subtype |
1.62857999999044E-05 |
ccA subtype-vs-ccB subtype |
3.541800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.68250000177306E-08 |
Normal-vs-N1 |
4.440800E-03 |
N0-vs-N1 |
9.834400E-01 |
|
|